News from Holden

Student Spotlight: Laura Hovenga

Laura HovengaGrinnell, IowaSummer Cancer Undergraduate Research Program at Iowa, summer 2023


Faculty awarded 2024 ACS seed grant through Holden Comprehensive Cancer Center

Four early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Researc


Holden Researchers to Present New Cancer Research Data at 2024 AACR Annual Meeting

A total of 19 abstracts from University of Iowa and UI Holden Comprehensive Cancer Center researchers have been accep


Advice for all ages on colorectal cancer

More and more people across the country are finding themselves affected by colorectal ca


Melanoma vaccine trial to start at UI

Trial will test whether a personalized mRNA vaccine combined with an immunotherapy prevents melanoma from recurring


New radiation therapy targets tumors more precisely

Software piloted at UI Health Care increases precision of MR-Linac technology  UI Health Care is the f


Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The findings were recently published in the journal Advanced Science.

From the Director

Dorfman Award Nominations

November 16, 2023 To: Holden Comprehensive Cancer Center Members